TFS HealthScience Deepens Partnership with Oncomatryx for Promising Pancreatic Cancer Drug Trial TFS HealthScience expands its partnership with Oncomatryx to support a Phase Ib trial on OMTX705, a new therapy for advanced pancreatic cancer, highlighting the urgent need for effective treatments in this field.

TFS HealthScience Deepens Partnership with Oncomatryx for Promising Pancreatic Cancer Drug Trial #USA #Lund #TFS_HealthScience #Oncomatryx #OMTX705

TFS HealthScience Expands Collaboration with Oncomatryx for Phase Ib Study of OMTX705 in Pancreatic Cancer TFS HealthScience is deepening its partnership with Oncomatryx to support a Phase Ib clinical trial of OMTX705 for treating advanced pancreatic cancer.

TFS HealthScience Expands Collaboration with Oncomatryx for Phase Ib Study of OMTX705 in Pancreatic Cancer #Sweden #Lund #TFS_HealthScience #Oncomatryx #OMTX705

TFS HealthScience Strengthens Partnership with Oncomatryx for OMTX705 Pancreatic Cancer Trials TFS HealthScience is expanding its collaboration with Oncomatryx for a Phase Ib trial of OMTX705, targeting advanced pancreatic cancer. This collaboration aims to accelerate innovative treatments.

TFS HealthScience Strengthens Partnership with Oncomatryx for OMTX705 Pancreatic Cancer Trials #USA #Lund #TFS_HealthScience #Oncomatryx #OMTX705

TFS HealthScience and Oncomatryx Collaborate for Advanced Pancreatic Cancer Trials TFS HealthScience expands its partnership with Oncomatryx for a Phase Ib trial of OMTX705 targeting advanced pancreatic cancer, aiming to develop innovative therapies.

TFS HealthScience and Oncomatryx Collaborate for Advanced Pancreatic Cancer Trials #USA #Lund #TFS_HealthScience #Oncomatryx #OMTX705